Diagnostix Network Alliance (DNA)  is a bio-technology sales organization representing a revolutionary technology which is the fastest, most accurate and effective method available to identify multiple infectious pathogens using molecular multiplexing.  This proprietary testing process, provided by DIATHERIX Laboratories, is a molecular differential diagnostic (MDD) tool trademarked as Tem-PCR™, an acronym for “Target Enhanced Multiplexing”.   DIATHERIX Laboratories’ licensed breakthrough technology Tem-PCR uses multiple specific genetic targets to identify different pathogens in a single molecular test.

For the past 25 years Real Time-PCR has been used as a molecular based testing platform to accurately identify a single pathogen. It is now possible using DIATHERIX Tem-PCR technology to identify multiple pathogens with molecular testing. The use of multiple genetic targets dramatically increases specificity and accuracy over other molecular testing platforms. Tem-PCR is the first truly effective molecular differential diagnostic technology that identifies multiple pathogens both viral and bacterial, co-infections, hospital acquired, community acquired strains, and associated drug resistance with genetic accuracy in four hours or less.